Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility
Authors:
- Alessia LaiALAlessia Lai
- Barbara CaimiBCBarbara Caimi
- Marco FranzettiMFMarco Franzetti
- Annalisa BergnaABAnnalisa Bergna
- Rossella VellecaRVRossella Velleca
- Antonella GattiAGAntonella Gatti
- Pier Luigi RossiPRPier Luigi Rossi
- Marco D’orsoMDMarco D’orso
- Fabrizio PregliascoFPFabrizio Pregliasco
- Claudia BalottaCBClaudia Balotta
- Giuseppe CalicchioGCGiuseppe Calicchio
Open Access
Abstract
Residents of long-term care facilities (LTCFs) have been dramatically hit by the COVID-19 pandemic on a global scale as older age and comorbidities pose an increased risk of severe disease and death. The aim of the study was to assess the quantity and durability of specific antibody responses to SARS-CoV-2 after the first cycle (two doses) of BNT162b2 vaccine. To achieve this, SARS-CoV-2 Spike-specific IgG (S-IgG) titers was evaluated in 432 residents of the largest Italian LTCF at months 2 and 6 after vaccination. By stratifying levels of humoral responses as high, medium, low and null, we did not find any difference when comparing the two time points; however, the median levels of antibodies halved overtime. As positive nucleocapsid serology was associated with a reduced risk of a suboptimal response at both time points, we conducted separate analyses accordingly. In subjects with positive serology, the median level of anti-S IgG slightly increased at the second time point, while a significant reduction was observed in patients without previous exposure to the virus. At month 6, diabetes alone was associated with an increased risk of impaired response. Our data provide additional insights into the longitudinal dynamics of the immune response to BNT162b2 vaccination in the elderly, highlighting the need for SARS-CoV-2 antibody monitoring following third-dose administration.Keywords
This publication has 39 references indexed in Scilit:
- High rates of SARS-CoV-2 seropositivity in nursing home residentsJournal of Infection, 2021
- Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational studyThe Lancet Microbe, 2020
- Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population studyThe Lancet Diabetes & Endocrinology, 2020
- Antibody tests for identification of current and past infection with SARS-CoV-2Cochrane Database of Systematic Reviews, 2020
- Elderly at time of COronaVIrus disease 2019 (COVID-19): possible role of immunosenescence and malnutritionGeroScience, 2020
- Asymptomatic SARS-CoV-2 Infection and COVID-19 Mortality During an Outbreak Investigation in a Skilled Nursing FacilityClinical Infectious Diseases, 2020
- Epidemiology of Covid-19 in a Long-Term Care Facility in King County, WashingtonNew England Journal of Medicine, 2020
- Vaccination in the elderly: The challenge of immune changes with agingSeminars in Immunology, 2018
- Severe Respiratory Illness Outbreak Associated with Human Coronavirus NL63 in a Long-Term Care FacilityEmerging Infectious Diseases, 2018
- Influenza in long‐term care facilitiesInfluenza and Other Respiratory Viruses, 2017